|
Symbol
|
AFOBIL | LCDMLK | YVALTQ | Z09BLZ | MBQZJB | LKVCLK | MAMMJB | MCBJJB | MCBVJB | MCCJJB | ACPDTQ | ACPETQ | CTBBKB | Z0B8QZ | AATJSG | ZMAE0V | MATRCH | MABBJB | MAPTJB |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Barrier Express Certificate | LUKB Autocallable Multi Barrier Reverse Convertible | Express Certificate | Express Note* | Multi Express Certifikat with European Knock-In | LUKB Autocallable Multi Barrier Reverse Convertible | Multi Express Certifikat with European Knock-In | Multi Express Certifikat with European Knock-In | Multi Express Certifikat with European Knock-In | Multi Express Certifikat with European Knock-In | Express Certificate with European Knock-In | Express Certificate with European Knock-In | Barrier Express Certificate | Express Note* | Apollon Oxygen | Callable VONCERT PHOENIX | Worst of Express Certificate | Express Certificate | Express Certificate |
|
Sous-jacent
|
Bouygues S.A. / Roche PS | Nestlé S.A. / Roche PS | Johnson & Johnson / Nestlé S.A. / Roche PS / Swiss RE AG | Nestlé S.A. / Roche PS / Swisscom N | Nestlé S.A. / Novartis AG / Roche PS | Nestlé S.A. / Novartis AG / Roche PS | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / Swisscom N / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / Swisscom N / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / Swisscom N / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Lonza Group N / Novartis AG / Roche PS | Novo Nordisk AS-SPONS ADR / Roche PS / Teva Pharmaceutical Industries Ltd. | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche PS | Bayer AG / Roche PS / Sanofi S.A. | Compagnie Financière Richemont SA / Lonza Group N / Roche PS / Sika AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
20.07.2027 | 16.10.2026 | 24.03.2028 | 25.03.2027 | 29.01.2027 | 18.06.2026 | 27.09.2027 | 03.04.2028 | 03.04.2028 | 03.04.2028 | 10.04.2029 | 10.04.2029 | 11.04.2028 | 24.06.2027 | 22.07.2026 | 09.03.2027 | 10.05.2028 | 04.02.2028 | 04.02.2028 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 100,00 | - | - | - | - |
|
Prix d'exercise
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Demande | 95,83 | - | 76,76 | 97,50 | - | - | - | - | - | - | 95,92 | 95,94 | 99,12 | - | 67,05 | 98,80 | 75,35 | - | - |
| Offre | - | - | - | - | - | - | - | - | - | - | 96,72 | 96,74 | 99,92 | - | 68,05 | 99,80 | 76,11 | - | - |